ArticleJournal of translational medicine2026

Efficacy and safety analysis of CAR-T cell salvage therapy in relapsed/refractory diffuse large B-cell lymphoma after failure of bispecific antibody treatment.

Fuli Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.